标题
The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-01-30
DOI
10.1038/s41598-018-20570-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
- (2017) Sang Hee Cho et al. Cancer Research and Treatment
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications
- (2016) A. Quintanal-Villalonga et al. DISEASE MARKERS
- Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site
- (2015) Vijay K. Ulaganathan et al. NATURE
- Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer
- (2015) LINGLING HU et al. ONCOLOGY REPORTS
- STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells
- (2015) CHUANHAI ZHANG et al. ONCOLOGY REPORTS
- The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer
- (2015) Hong-ping Huang et al. OncoTargets and Therapy
- Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis
- (2014) Victoria Moneo et al. BMC CANCER
- Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
- (2014) T Nitta et al. BRITISH JOURNAL OF CANCER
- JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
- (2014) RENG-YUN LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis
- (2014) Ming Lu et al. PLoS One
- FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer
- (2013) Hong-mei Fang et al. ACTA PHARMACOLOGICA SINICA
- FGFR3 has tumor suppressor properties in cells with epithelial phenotype
- (2013) Marie Lafitte et al. Molecular Cancer
- AKT activation by N-cadherin regulates beta-catenin signaling and neuronal differentiation during cortical development
- (2013) Jianing Zhang et al. Neural Development
- N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties
- (2013) X Qian et al. ONCOGENE
- Prognostic Significance of Twist and N-Cadherin Expression in NSCLC
- (2013) Linping Hui et al. PLoS One
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma
- (2011) K Araki et al. BRITISH JOURNAL OF CANCER
- Biospecimen reporting for improved study quality (BRISQ)
- (2011) Helen M. Moore et al. CANCER CYTOPATHOLOGY
- FGFR-4 Arg388 Enhances Prostate Cancer Progression via Extracellular Signal-Related Kinase and Serum Response Factor Signaling
- (2011) W. Yu et al. CLINICAL CANCER RESEARCH
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
- (2011) Hua Xiong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma
- (2011) Yuan Yang et al. MOLECULAR CARCINOGENESIS
- Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to Extracellular Matrix Degradation
- (2010) N. Sugiyama et al. CANCER RESEARCH
- FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex
- (2010) N. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation
- (2009) A. Roidl et al. CLINICAL CANCER RESEARCH
- FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung
- (2009) Felicia S. Falvella et al. INTERNATIONAL JOURNAL OF CANCER
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now